Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Sutro Biopharma Inc (NASDAQ: STRO) was $0.94 for the day, down -4.26% from the previous closing price of $0.98. In other words, the price has decreased by -$4.26 from its previous closing price. On the day, 0.51 million shares were traded. STRO stock price reached its highest trading level at $0.9893 during the session, while it also had its lowest trading level at $0.9109.
Ratios:
Our analysis of STRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.12 and its Current Ratio is at 3.12.
Wedbush Downgraded its Outperform to Neutral on March 14, 2025, whereas the target price for the stock was revised from $8 to $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 15 ’25 when Gerber Hans-Peter bought 17,000 shares for $0.80 per share. The transaction valued at 13,607 led to the insider holds 71,832 shares of the business.
Chow Gregory K. bought 19,750 shares of STRO for $15,998 on Oct 15 ’25. The CFO now owns 19,750 shares after completing the transaction at $0.81 per share. On Oct 15 ’25, another insider, Chung Jane, who serves as the Chief Executive Officer of the company, bought 12,500 shares for $0.80 each. As a result, the insider paid 10,011 and bolstered with 122,850 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STRO now has a Market Capitalization of 79874232 and an Enterprise Value of -105663768. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.76. Its current Enterprise Value per Revenue stands at -1.011 whereas that against EBITDA is 0.668.
Stock Price History:
The Beta on a monthly basis for STRO is 1.62, which has changed by -0.7762557 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, STRO has reached a high of $4.60, while it has fallen to a 52-week low of $0.52. The 50-Day Moving Average of the stock is -0.84%, while the 200-Day Moving Average is calculated to be -6.36%.
Shares Statistics:
STRO traded an average of 846.70K shares per day over the past three months and 752820 shares per day over the past ten days. A total of 84.72M shares are outstanding, with a floating share count of 78.22M. Insiders hold about 7.73% of the company’s shares, while institutions hold 66.26% stake in the company. Shares short for STRO as of 1760486400 were 2506582 with a Short Ratio of 2.96, compared to 1757894400 on 2517815. Therefore, it implies a Short% of Shares Outstanding of 2506582 and a Short% of Float of 2.98.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.28 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$1.03 and -$1.03 for the fiscal current year, implying an average EPS of -$1.03. EPS for the following year is -$1.25, with 1.0 analysts recommending between -$1.25 and -$1.25.
Revenue Estimates
A total of 10 analysts have provided revenue estimates for STRO’s current fiscal year. The highest revenue estimate was $113.2M, while the lowest revenue estimate was $81M, resulting in an average revenue estimate of $98.69M. In the same quarter a year ago, actual revenue was $62.04M
